Suvretta Capital Management »

Teva Pharmaceutical Industries shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $5.1M 497k 10.20
2015-12-31 $94M 1.4M 65.64
2015-03-31 $61M 981k 62.30
2014-03-31 $11M 214k 52.84

More positions owned by Suvretta Capital Management

Royalty Pharma Shs Class A (RPRX)
Biohaven (BHVN)
Arcellx Common Stock (ACLX)
Horizon Therapeutics Pub L SHS
Insmed Com Par $.01 (INSM)
Meta Platforms Cl A (META)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Intra Cellular Therapies (ITCI)
Microsoft Corporation (MSFT)
Kura Oncology (KURA)
Wynn Resorts (WYNN)
Marinus Pharmaceuticals Com New (MRNS)
89bio (ETNB)
General Electric Com New (GE)

View all positions for Suvretta Capital Management

Top funds holding Teva Pharmaceutical Industries

Ion Asset Management
Phoenix Holdings
Migdal Insurance & Financial Holdings
Millennium Management
Citadel Advisors
AustralianSuper Pty
Sound Shore Management
Goldman Sachs Group
Abrams Capital Management
Soleus Capital Management
Alyeska Investment Group
Legal & General Group
Holocene Advisors
Arrowstreet Capital, Limited Partnership
Sphera Funds Management

View all funds holding Teva Pharmaceutical Industries